Andrei Shustov
Technik-/Wissenschafts-/F&E-Leiter bei CELLECTAR BIOSCIENCES, INC.
Vermögen: 166 212 $ am 30.04.2024
Aktive Positionen von Andrei Shustov
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.02.2023 | - |
Karriereverlauf von Andrei Shustov
Ehemalige bekannte Positionen von Andrei Shustov
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - | - |
Ausbildung von Andrei Shustov
| S. I. Georgievsky's Medical Academy | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Russland | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Börse
- Insiders
- Andrei Shustov
- Erfahrung
